TheraNova is a venture studio and incubator focused on the development of medical devices, guiding projects from initial concept through clinical trials and regulatory approval to commercialization. The company employs a rapid and capital-efficient approach to innovation, which encompasses all necessary elements of medical device development, including engineering, clinical study execution, and adherence to FDA guidelines. TheraNova has successfully spun out 20 companies, raised over $35 million in government grants, and secured more than $400 million for its portfolio companies. The firm has also achieved 12 regulatory clearances and approvals from the FDA and has filed over 120 patents, demonstrating its commitment to advancing healthcare solutions.

The technological capabilities of TheraNova include a wide range of engineering disciplines such as mechanical, electrical, and software engineering, as well as expertise in manufacturing processes like rapid prototyping and 3D printing. The team is well-versed in quality system implementation and has significant experience in clinical research across various regions, including the United States, Europe, and South America. TheraNova's collaborative model also involves working closely with reimbursement consultants to ensure that their innovations not only meet regulatory standards but also improve patient outcomes, expand healthcare access, and reduce costs for patients and payers.

United States

Located in San Francisco CA, TheraNova is a medical device development company focused on developing solutions to large markets with unmet needs.  TheraNova accomplishes this through its mission to improve outcomes, decrease costs and expand access to healthcare.

TheraNova

Company Details